greeksoup/ stock research

Dolby Laboratories (DLB) FY2019 results: revenue $1.2 billion, up 17.7% on the year

Dolby Laboratories, Inc. (DLB) reported revenue of $1.2 billion for fiscal 2019, the year ended 27 September 2019, up 17.7% on the year before. Net income was $255 million, up 511.2%, and diluted earnings per share $2.44. The figures are the company's own, from the 10-K it filed with the SEC on 25 November 2019.

Revenue
$1.2 billion
+17.7% on the year
FY2012FY2019
Operating margin
20.7%
17.4% a year earlier
FY2012FY2019
Net income
$255 million
+511.2% on the year
FY2012FY2019
Diluted EPS
$2.44
+525.6% on the year
FY2012FY2019

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2019FY2018FY2017On the yearLast 8 years
Revenue1,2421,0551,081+17.7%
Cost of revenue161128118+26.1%
Gross profit1,081927963+16.6%
Gross margin87.0%87.9%89.1%
Research and development238237233+0.5%
Operating income257184247+40.1%
Operating margin20.7%17.4%22.9%
Interest expense0.20.20.1-14.1%
Pre-tax income282196255+43.8%
Income tax26.815448.0-82.6%
Effective tax rate9.5%78.5%18.8%
Net income25541.7206+511.2%
Net margin20.5%4.0%19.1%
Diluted EPS$2.44$0.39$2.00+525.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2019FY2018FY2017On the yearLast 8 years
Operating cash flow328352378-7.0%
Capital expenditure96.372.899.6+32.2%
Free cash flow231279278-17.2%
Free cash flow margin18.6%26.5%25.7%
Cash from investing-56.278.1-158
Cash from financing-385-134-107
Depreciation and amortisation85.181.384.3+4.7%
Share-based compensation76.671.265.3+7.5%
Buybacks341150100+126.3%
Dividends paid77.566.257.1+17.1%
Dividend per share$0.79$0.67$0.58+17.9%
Diluted shares, weighted105m107m103m-2.2%

Balance sheet

$ millionFY2019FY2018FY2017On the yearLast 8 years
Shareholders' equity2,3072,3642,137-2.4%
Non-controlling interest5.76.67.1-13.5%
Debt0.00.00.0
Operating lease liabilities0.0n/an/a
Other liabilities509495390+2.8%
Total liabilities and equity2,8222,8652,534-1.5%
Fixed assets537514485+4.5%
Goodwill335328311+2.1%
Intangible assets181184190-1.7%
Investments299366562-18.4%
Cash and equivalents797918634-13.2%
Receivables18916673.8+13.8%
Inventory32.326.225.1+23.4%
Other assets451363252+24.3%
Total assets2,8222,8652,534-1.5%

10-K for the year ended 27 September 2019, filed 25 November 2019: the filing.